EP Patent

EP4183391A1 — Pharmaceutical composition and use thereof

Assigned to Shenzhen Salubris Pharmaceuticals Co Ltd · Expires 2023-05-24 · 3y expired

What this patent protects

The present invention relates to the technical field of the use of a pharmaceutical composition, and in particular relates to a pharmaceutical composition and the use thereof.

USPTO Abstract

The present invention relates to the technical field of the use of a pharmaceutical composition, and in particular relates to a pharmaceutical composition and the use thereof.

Drugs covered by this patent

Patent Metadata

Patent number: EP4183391A1
Jurisdiction: EP
Classification: —
Expires: 2023-05-24
Drug substance claim: No
Drug product claim: No
Assignee: Shenzhen Salubris Pharmaceuticals Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.